Eris Biotech
YC W24Lehi, US · Founded 2023 · 2 employees · 1 known investors
Eris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
Founders & leadership· Y Combinator alumni (W24)
Eris Biotech was founded in 2023 by Rachel Garlick and Evita Weagel.
RG
Rachel GarlickinCo-FounderRachel Garlick holds a PhD in Immunology from Dartmouth College and has developed cancer immunotherapies. At Eris Biotech, she is building cancer drugs designed to activate immune responses against cancer.
EW
Evita WeagelinCo-Founder & CEOEvita Weagel holds a PhD in microbiology and molecular biology with focus on cancer immunology, and is developing immunotherapies targeting cancer.
Investors · 1
Images
Competitors · 6
by search overlap
Orionis Biosciences5 shared keywordsOrionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses. It develops therapeutics for cancer, autoimmune diseases, and neurodegenerative disorders through collaborations with industry and academic institutions.
IRIS MEDICINE4 shared keywordsIris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.
Exelixis4 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Amyris4 shared keywordsAmyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products. Founded in 2003, the company focuses on sustainable, bio-based sourcing of molecules.
IQVIA4 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Fortis Life Sciences3 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Companies competing with Eris Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Eris Biotech do?
- Eris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
- Who founded Eris Biotech?
- Eris Biotech was founded by Rachel Garlick, Evita Weagel in 2023.
- Who are Eris Biotech's investors?
- Eris Biotech's investors include Y Combinator.
- Where is Eris Biotech headquartered?
- Eris Biotech is headquartered in Lehi, US.